something me and you share , fun.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
sell sell sell if you have HIPHD shares!
Today is Friday , FNMA....please keep money in your bank....sell sell sell ...good weekend ..I make 50k in two day ...i will come back for more when it gets staple .....FnF
http://www.fanniemae.com/portal/about-us/investor-relations/quarterly-annual-results.html
After Fannie, Freddie's wild ride, future is murkyFont size: A | A | A
12:20 PM ET 3/14/14 | MarketWatch
By Ruth Mantell, MarketWatch
It's fair to say that Fannie Mae and Freddie Mac investors had a bumpy ride this week.
On Tuesday common shares for Fannie (FNMA) and Freddie (FMCC) plunged 31% and 27%, respectively, after lawmakers announced a blueprint to wind down the federally controlled mortgage buyers. Losses were extended Wednesday, but then investors tiptoed back into the shares on Thursday.
Preferred shares in Fannie (FNMAS) and Freddie (FMCKJ) also dropped this week, but there was less panic among these investors. Many of these holders are in their positions for the long haul, and these series each fell less than 4% on Tuesday.
Despite this activity, the outlook hasn't changed much for the firms. That is, it's still pretty murky.
"You're probably going to have continued volatility in these asset classes as investors try to gauge what the end game is," said Corey Boles, an analyst at Eurasia Group, a political-risk consultancy.
Yes, U.S. senators are taking an important step by introducing a piece of major housing-finance reform with bipartisan support. But analysts agree that there are vanishing chances for the Senate to approve a bill this year. Even if senators make progress next year on the legislation, an agreement still must be reached with U.S. House lawmakers, and Republicans there want the government to play a smaller role in a reformed housing-finance system than what senators have proposed.
"I am skeptical of any approach that does not end the permanent government guarantee in the secondary mortgage market. Such an approach could very well perpetuate the cycle of boom, bust and bailout we tragically just witnessed," Rep. Jeb Hensarling, a Republican of Texas and chairman of the House Financial Services Committee, said after senators announced their reform agreement on Tuesday.
House Democrats may introduce a bill in about a month that could enable Fannie and Freddie to be sold as independent companies, though their function in a reformed housing-finance system would dramatically change. Rep. John Delaney of Maryland, one of the proposal's authors, told MarketWatch that if Fannie and Freddie have a role in a reformed housing-finance system, he wouldn't be against investors receiving some compensation, though it's unclear what the value of the firms would be.
The Fannie-Freddie puzzler this week was the extreme reaction among investors to news of the legislation. The bill contained no surprises about lawmakers' intent to eliminate the government sponsored enterprises. Indeed, the new proposal uses a prior plan for winding down the GSEs as its base text, with lawmakers making only a handful of changes in recent months to the underlying proposals.
"Taxpayers should ask for their money back," said Edwin Groshans at Height Analytics.
--Ruth Mantell
Next: Fannie, Freddie shares skyrocket over past year
-Ruth Mantell; 415-439-6400; AskNewswires@dowjones.com
Despite the carnage this week in Fannie and Freddie shares, the series have posted tremendous growth over the past 12 months. Common shares of Fannie and Freddie are up each more than 1,000%, while the most heavily traded preferred series each climbed more than 300%.
Given that the companies are prevented from building capital, the lofty growth in share prices may surprise some observers. The GSEs have been in conservatorship for more than five years. Because of a 2012 amendment to the government's bailout agreement, Fannie and Freddie send all of their profits to the U.S. Treasury Department.
But shareholders see reason for hope in two scenarios. First, if lawmakers do nothing for long enough, some investors expect the conservatorship to end, enabling shareholders to obtain compensation. Second, shareholders have filed suits to challenge the 2012 bailout-agreement amendment, and hope that the courts will decide in their favor.
Many see a favorable court decision as shareholders' best bet to nab some cash. Indeed, in a Thursday interview on Bloomberg Television, Sen. Mike Crapo of Idaho, the leading Republican on the banking committee and co-author of the new housing-finance-reform bill, said in response to a question about how his legislation would deal with shareholders: "The answer is going to come in court rather than in Congress."
Next: Fannie, Freddie shareholders making taxpayers whole
-Ruth Mantell; 415-439-6400; AskNewswires@dowjones.com
One argument that shareholders offer to support their claims for compensation is that Fannie and Freddie are making taxpayers whole on the funds that were provided to support the once-flailing firms.
Including dividends sent to Treasury this quarter, taxpayers will have received a cumulative total of more than $200 billion from the firms, exceeding bailout funds of less than $190 billion, according to the most recent quarterly financial statements from Fannie and Freddie.
The firms started taking federal bailout funds in 2008. Thanks to a rebounding housing market, they returned to profit in the last two years. Indeed, if the terms of the amended bailout agreement remain unchanged, taxpayers are on track to net $179 billion from the firms by the end of fiscal 2024, according to recently released White House budget documents.
Next: Home prices jump as market recovers
-Ruth Mantell; 415-439-6400; AskNewswires@dowjones.com
But critics say Fannie and Freddie's return to profit is largely thanks to government intervention, actions that were made to help stabilize the country's housing market and not to enrich shareholders.
Home prices sprinted higher last year, and the firms were able to reduce their provisions for loan losses. A large chunk of profits last year was also due to non-recurring legal settlements and tax benefits.
Looking forward, company officials said profit levels will fall from 2013's levels. For one, home prices are expected to slow down this year. Also, the companies won't benefit from the one-time tax and legal gains that pumped up last year's profits.
Next: Fannie, Freddie still back lion's share of mortgages
-Ruth Mantell; 415-439-6400; AskNewswires@dowjones.com
One argument offered in favor of keeping Fannie and Freddie around post-conservatorship comes from those who say the firms offer much-needed stability as the housing market recovers.
They certainly still play a large role in the helping to make credit available. Last year Fannie and Freddie backed about 61% of mortgages originated for one-to-four family homes, according to data from Inside Mortgage Finance, a publication that closely follows industry trends.
But that share may decline soon.
"I would expect it to move down to 50% or less in the next couple of years, as the housing market continues to recover and more money flows into the non-agency or private lending business," said Guy Cecala, publisher at Inside Mortgage Finance.
Next: Mortgage availability on the rise
-Ruth Mantell; 415-439-6400; AskNewswires@dowjones.com
Until private capital starts playing a larger role, Fannie and Freddie will continue to provide a useful service. Access to home loans is key for the market's continued recovery, Obama administration officials recently said.
"Stronger housing demand depends critically on the easing of credit standards (that might have been over-tightened following the financial crisis), particularly for first-time homebuyers," the White House's 2014 economic report said.
There has been some thawing when it comes to obtaining a home loan. A gauge of mortgage-credit availability ticked up last month, and has been heading higher for two years, the Mortgage Bankers Association reported. MBA's gauge of mortgage-credit availability rose to 113.5 in February from 113 in January, and 109.1 in February 2013. The index was set to equal 100 in March 2012.
This February's reading was a record high for the series, which goes back to early 2011. For those worried about recent easing, wondering whether risky lenders are setting up the economy for another disaster, consider this: MBA's gauge would have been about 800 during the bubble year of 2007.
Next: Some big banks easing mortgage standards
-Ruth Mantell; 415-439-6400; AskNewswires@dowjones.com
Healthy jobs growth is key to support the housing market, but if borrowers can't get a loan, that's going to hold back further progress. Large banks, in particular, are behind some recent easing on mortgage standards.
The Fed reported that a bigger share of large banks last quarter eased credit standards for prime mortgages to buy a home than the share that tightened standards. The Fed reported that 16.7% of large banks "somewhat" eased credit standards, compared with 5.6% that tightened.
-Ruth Mantell; 415-439-6400; AskNewswires@dowjones.com
> Dow Jones Newswires
March 14, 2014 12:20 ET (16:20 GMT)
Copyright (c) 2014 Dow Jones & Company, Inc.
There are no guilt when it comes to money ...If the government not bail FnF out , there are not thing to talk now...gamble...gamble ..gamble..! FnF
buy buy buy now ..FNMA ...1$ become 2$
yes..to 10$ if no ----hold not thing ...big gambling moment..shit run FNMA
FMCC FNMA: Freddie Mac (FMCC) recovered from previous day's losses to gain 9.2% while Fannie Mae (FNMA) rebounded 6.9%. Both stocks were pressured following a proposal from U.S. lawmakers to reform housing finance that will result in the liquidation of the mortgage buyers.
https://www.google.com/search?q=FMCC+FNMA%3A+Freddie+Mac+(FMCC)+recovered+from+previous+day%27s+losses+to+gain+9.2%25+while+Fannie+Mae+(FNMA)+rebounded+6.9%25.+Both+stocks+were+pressured+following+a+proposal+from+U.S.+lawmakers+to+reform+housing+finance+that+will+result+in+the+liquidation+of+the+mortgage+buyers.&oq=FMCC+FNMA%3A+Freddie+Mac+(FMCC)+recovered+from+previous+day%27s+losses+to+gain+9.2%25+while+Fannie+Mae+(FNMA)+rebounded+6.9%25.+Both+stocks+were+pressured+following+a+proposal+from+U.S.+lawmakers+to+reform+housing+finance+that+will+result+in+the+liquidation+of+the+mortgage+buyers.&aqs=chrome..69i57&sourceid=chrome&espv=210&es_sm=93&ie=UTF-8
Sorry all , I don't own this stock ! But I dear my dear !
Share Structure
Market Value1 $57,096,947 a/o Feb 28, 2014
Shares Outstanding 3,086,321,486 a/o Feb 07, 2014
Float 1,032,648,198 a/o Feb 07, 2014
Authorized Shares 4,900,000,000 a/o Sep 30, 2013
http://www.otcmarkets.com/stock/MYEC/company-info
I see this S'''T long time . it's still S'''T! Take P if you can !
I have been known MYEC , check
you maybe right ! or you should check AS4900000000 shares ! this number is Drinking your money than i have right now ! S...is...S!
Oh dear MF , I don't really like MYEC ...It looks good right now...but i don't how much my dear in vole in this scam ...this is something not for me .GLWU ! But you want to boom this MYEc ! I can show you how ... but maybe we both go to J for this ... with all my dear!
yeh, that's why i did not buy that wife back ,so i took new one...wait until i sold her for PHOT shares kakaka
F!TX worth $5B so PHOT $3B at-list , so 2$ a share and party at your house , my new wife don't want party not good for my health kakaka
Alert Phot Buy Buy Buy for 2$ a share!
FB down ,TWTR will up ???
what's happening today? Fitx is s...t look like s...t , sell sell sell so i can buy buy buy
uplist?..5$ Fnma
uplist?..5$ Fnma
that video you showed , Hiphd is real ..ka ka ka
good , I am slap HIPHD @1.5$ woo woo ...buy buy buy
look like sell sell sell in 12days , this is a scam for me and I gone not look back!
If you are holding This Stock , time to slap HIPHD Ask....buy buy buy to price the price.
He said the truth , 20 shares @ 2$ is my bought on last Friday , HipHD already set their price for merger , good luck !!!!
oh I am at FITX , to busy not attend their shares holder , HipHD for the cerlerberties party .. ka ka ka
yep , so i can buy buy buy kakaka but today , markets close...goog to see ya buddy ,,,ka ka ka
Among individual stocks, Groupon Inc. (GRPN) slid 16% after the daily-deals company late Thursday delivered a disappointing outlook.
look Sell sell sell to me
BUY @3$$$$ ???HIPHD buy buy buy sell 10c not bad , it's just a being of HIPHD .American Premium Water Corporation, formerly Expert Group, Inc, intends to focus on developing brands, marketing, promoting, bottling and distributing alkaline bottled water in glass. The Company has identified a range of products. The Company's product includes Natural Artesian Water, Mountain Spring Water, and Purified Drinking Water. The Company intends to make agreements with distributors, including grocery stores, hotels, restaurants, brand ambassadors, celebrity endorsements, new brands, suppliers and executive additions as appropriate.
HIPHD Par Value 0.001
Chicago, IL – 21 February 2014 — (Tech Sonian) – US stocks and the dollar mostly gained yesterday on data showing US factory activity accelerated in February at its fastest pace in nearly four years, but surveys showing a soft patch in China and parts of Europe dragged on global equity markets.
Markit’s preliminary US Manufacturing Purchasing Mana-gers Index jumped to 56.7 in February, its highest level since May 2010, from a final reading for January of 53.7. A reading above 50 in-dicates expansion.
“The manufacturing data is extremely positive, especially coming after a spate of bad news at a time when the (Federal Reserve) seems committed to slowing stimulus,” said Nicholas Colas, chief market strategist at the ConvergEx Group in New York.
American Premium Water Corporation (HIPH) provided the update to the investment community and shareholders of the company. In order to attain the Corporation’s vision and business strategy of Marketing, Promoting and Branding HIPH bottled water.
American Premium Water Corp (OTCMKTS:HIPH) settled 69.23% lower at $0.0008on below-normal volume of 110.32M shares during the last trading day. The stock has its 12-month high at $0.00and 52-week low price was $0.00.
http://www.techsonian.com/traders-alert-american-premium-water-corp-otcmktshiph-turbine-truck-engines-incotcbbtteg-gdf-suez-sa-adrotcmktsgdfzy-mitsubishi-estate-co-ltd/12131971/
HIPHD ...'WARNING' sight is off from OTC markets ...BUY BUY BUY
Share Structure
Market Value1 Not Available
Shares Outstanding 0 a/o Feb 21, 2014
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders
Shareholders of Record Not Available
Security Notes
Capital Change=shs decreased by 1 for 25 split. Pay date=04/06/1999.
Capital Change=shs decreased by 1 for 1000 split. Effective date=3-31-03
Capital Change=shs decreased by 1 for 20 split. Pay date=7-27-04.
Capital Change=shs decreased by 1 for 1000 split Pay date=10/17/2007.
Capital Change=shs decreased by 1 for 500 split Pay date=01/09/2009.
Capital Change=shs decreased by 1 for 1000 split. Ex-date=02/21/2014.
http://www.otcmarkets.com/stock/HIPHD/company-info
Creative Edge Nutrition, a Michigan-based nutritional supplements company, has come up with an interesting plan to legally sell pot on a large scale.
The company believes it could generate as much as $5 billion a year at more than 80% profit by selling medical pot in Canada.
Creative Edge launched a Canadian subsidiary, called CEN Biotech, and hopes to grow medical marijuana in that country, up to 1.3 million pounds annually.
"1.3 million pounds equates to about $5 billion a year — you're looking at $8 gram — at 80-87% profit," CEO Bill Chaaban told Business Insider.
That would be a pretty big feat for Creative Edge Nutrition, which is trading for about 9 cents right now. Creative Edge is an "over-the-counter"/Pink Sheets stock, meaning it's a high-risk stock not traded on a stock exchange.
Creative Edge's application to grow pot in Canada hasn't yet been approved, Chaaban acknowledges. And it's competing with several hundred applicants, industry site Marijuana Index reports.
But he shared these details could the company get the nod:
Canada changed its medical marijuana model into something called "super growers" where companies grow pot under strict pharmaceutical regulation and sell it directly to consumers. There will be no dispensaries. As of April 1, people will no longer be allowed to grow their own pot, reports the Vancouver Sun.
Creative Edge plans to sink $12 million into building a facility that can grow a huge amount of pot.
The $12 million is coming from a company called GrowLife that makes marijuana growing equipment and is financing the facility in exchange for a 25% stake, Chaaban says.
Venture capital investment wasn't a good option. VCs willing to invest in pot ventures want to take "upwards of 70%" equity, Chaaban says.
This plan works in part because, Creative Edge, the parent company, is located physically close to Canada in Madison Heights, Mich., a suburb of Detroit. The site for the Canadian facility is in Lakeshore, Ontario, right across the border from Detroit.
CEN Biotech says it could even be possible to sell its pot internationally, to 29 countries that have pharmaceutical trade agreements with Canada and view marijuana as a legal narcotic. Israel is one of the biggest of those markets.
Obviously, the legal marijuana industry is young and full of risk. But here's a look into the reason why this CEO is eager to take on that risk.
Business Insider: Tell me how this idea began.
Bill Chaaban: We started in the nutrition supplement business, launched a brand called Cenergy and over the years acquired some e-commerce sites that sell just about every brand of sports and dietary supplements.
About a year and a half ago, we decided we wanted to get into medical marijuana. I canvassed the regulatory landscape and I found it was too risky for a public company to grow and sell medical marijuana.
Then an opportunity presented itself in Canada.
BI: Can you tell me more about the Canadian marijuana model?
BC: The Canadian medical marijuana program is run by Health Canada which is like Canada's FDA. They are changing their system in Canada to license large super growers to supply the whole market. You grow it and sell it directly to the patient, there would be no dispensaries.
BI: Does that mean that there will only be a few companies supplying all of Canada?
BC: There's no limit on the number of companies they are going to license, however getting a license is very difficult. A lot of cities in Canada don't want commercial growers in their cities and you have to have the local police and fire approval.
Our license, that we applied for, is for import/export and sale of medical marijuana and we applied to grow and sell 1.3 million pounds per calendar year.
BI: Without dispensaries how will this work?
BC: Once you become a licensed producer, you'll be put on the Health Canada website. As of April 1, Canada won't require a card. You go to your health care provider — a physician, a physician's assistant, a nurse practitioner, a dentist — anyone able to prescribe a narcotic — and they write a prescription.
You send the prescription into a licensed producer and you pay the producer directly. It's shipped to your home via courier ... everything is shipped with a secured carrier with chain of custody.
In Colorado, there's a growing industry of "edibles," food and drinks that includes pot. Is that happening in Canada?
No. Not at all. It's basically just the bud, not edibles.
What are your plans to sell marijuana in the U.S. market?
We've hired lobbyists in Michigan to support some bills in Michigan, like Bill 660, which actually reflects the Canadian market slightly, where Michigan is calling for super growth authorities ... also Michigan wants medical marijuana to only be dispensed in a pharmacy.
Those bills have passed and we've already found locations in Michigan and we're in talks with Michigan legislature. We're just waiting for [a change in] federal law.
You mention import/export. What other countries are involved and how?
Under the U.N. convention of control of narcotics, there's 29 countries that view medical marijuana as a narcotic. So every single one of those countries will be a market we're going to try to sell to because we'll be backed by the Canadian government.
[For instance,] Israel and Canada have a free trade agreement and over the last 25 years, Israel and Canada have been supplying each other's populations with medicine.
Health Canada also allows importation. We'll be able to import seeds from any of those countries where growing medical marijuana is allowed: Netherlands, Columbia, Mexico, Israel and other countries.
What costs are involved?
Our investment in our [Canadian growing] facility. It will cost $12 million to build it. And we're keeping a $4 million war chest for operations, lobbying, etc.
Taxes will be remitted to Canada. It can be taxed from 5%-13%, depending on the Province.
We'll be growing the marijuana in a sterile environment, using the standards as if we were manufacturing drugs. Any employee comes to work has their temperature measured. If they are ill, they are not allowed into the facility. People wear scrubs, hair nets, uniformed. You have to have third-party lab testing.
What kind of revenue and profits do you expect to make?
1.3 million pounds equates to about $5 billion a year. You're looking at $8 gram. You're selling by the gram at retail level. Wholesale will be by the pound, but majority of sales will be retail. Profit margin: 80-87 percent profit.
Will it be as lucrative in the U.S. as it will in Canada?
That depends on the model. Obviously, if you are growing at scale, the costs come down. The largest players are going to stand out and be more profitable than the smaller players.
How did you raise the money you needed?
We entered into a collaborative partnership with a company called GrowLife and sold them 25% of our revenue stream. They are funding our operations, providing financing and equipment. They are in the picks and shovels part of the business. They sell lighting and equipment to other growers.
It's very hard to get bank financing and it's hard to get VC financing. You can get it from them, but the problem with VCs is that they are all looking at having way too much equity. They wanted upwards of 70%.
SEE ALSO: Here's How Easy It Is To Buy Weed From A Store In Colorado Now
Read more: http://www.businessinsider.com/company-plans-to-make-5b-selling-pot-2014-2#ixzz2tdkERB7O
This Public Company Has A Plan To Make $5 Billion A Year From Selling Pot
Creative Edge Nutrition, a Michigan-based nutritional supplements company, has come up with an interesting plan to legally sell pot on a large scale.
The company believes it could generate as much as $5 billion a year at more than 80% profit by selling medical pot in Canada.
Creative Edge launched a Canadian subsidiary, called CEN Biotech, and hopes to grow medical marijuana in that country, up to 1.3 million pounds annually.
"1.3 million pounds equates to about $5 billion a year — you're looking at $8 gram — at 80-87% profit," CEO Bill Chaaban told Business Insider.
http://www.businessinsider.com/company-plans-to-make-5b-selling-pot-2014-2
that was me, Q4 look very good kakaka
Is Q4 coming out today? Fmna ? any idea?
i hold this 6 yrs , and will hold longer !wht's the Hesg?
sell sell sell ...now HiFp just for me ...i love this scam ...sell sell sell
kakaka buy buy buy clear sky for FB !!!200$ a share with (FIAT)buy buy buy
good work , go HIPH
What the HESG kakaka 20B A/S kakaka what's a joke!!!???kakaka
sell sell sell FDA-EU search for MJNA
Simultaneous to the marketing approvals, MJNA and Canipa Holdings are working with authorities to provide European FDA-level clinical studies. While there have been numerous, positive studies on the effects of Cannabinoids (CBD’s), the Company’s specific CBD-infused products will be studied by selected EU medical universities. Initially it is anticipated that the studies will prove the safety and efficacy of these products in the treatment of chronic pain.
Further clinical trials will be commissioned to study the effect of the CBD-infused products on muscle spasticity and nausea. Muscle spasticity, which affects many spinal cord injury and neuro-degenerative patients (such as Multiple Sclerosis) can create pain through nerve entrapment. Nausea and vomiting are common symptoms of cancer chemotherapy patients.
The goal of the clinical trials will be to make formal European medical claims as to the effectiveness of CBD-infused Dixie X and CanChew gum in the treatment of chronic pain, muscle spasticity and nausea. Then to have the products approved as a doctors prescribed medication and therefore qualify for insurance reimbursement.
http://www.medicalmarijuanainc.com/index.php/press/22-press-releases/2012-press-releases/148-medical-marijuana-inc-s-canipa-holdings-drive-dixie-x-and-canchew-gum-toward-eu-marketing-approval-and-clinical-development